High concentrations of glucose induce insulin resistance, impair insulin secretion, and affect hepatic glucose production in a manner that mirrors type 2 diabetes, and hexosamines mimic many of these effects. This has led to the hypothesis that cells use hexosamine flux as a glucose- and satiety-sensing pathway. The hexosamine hypothesis for glucose sensing has been validated by overexpressing the rate-limiting enzyme for hexosamine synthesis, GFA in several tissues including muscle, liver, fat, and beta cells. Excess hexosamine flux leads to a coordinated response whereby fuel is shunted toward long term storage, mirroring the """"""""thrifty phenotype"""""""" and resulting ultimately in obesity, hyperlipidemia, and insulin resistance. The results suggest a mechanism by which chronic overnutrition leads to the phenotype of type 2 diabetes. Studies are proposed to investigate (a) the full extent of consequences of increased hexosamine flux for the organism; and (b) the mechanisms underlying these changes.
The specific aims are: 1. Based on the previous demonstration that overexpression of GFA in striated muscle plus fat causes insulin resistance, we propose to overexpress GFA separately in these tissues. Using the aP2 promoter to target to fat, glucose and fat metabolism, insulin sensitivity, and leptin levels will be assessed in the whole animal and in isolated fat cells. Targets for gene regulation by hexosamines will be identified. 2. Parallel experiments will be performed in mice overexpressing GFA only in striated muscle to determine if muscle becomes insulin resistant secondary to signaling from fat. 3. The investigators will study why GFA overexpression in liver results in increased liver glycogen, increased free fatty acid (FFA) and triglyceride levels and eventually obesity and insulin resistance. 4. The investigators will test the hypothesis that hexosamines exert their effects through O-linked glycosylation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043526-12
Application #
6517205
Study Section
Metabolism Study Section (MET)
Program Officer
Laughlin, Maren R
Project Start
1999-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
12
Fiscal Year
2002
Total Cost
$262,500
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Soesanto, Yudi; Luo, Bai; Parker, Glendon et al. (2011) Pleiotropic and age-dependent effects of decreased protein modification by O-linked N-acetylglucosamine on pancreatic ?-cell function and vascularization. J Biol Chem 286:26118-26
Cooksey, Robert C; McClain, Donald A (2011) Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway. Amino Acids 40:841-6
Stapleton, David; Nelson, Chad; Parsawar, Krishna et al. (2010) Analysis of hepatic glycogen-associated proteins. Proteomics 10:2320-9
Shakya, Arvind; Cooksey, Robert; Cox, James E et al. (2009) Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nat Cell Biol 11:320-7
Taylor, Rodrick P; Geisler, Taylor S; Chambers, Jefferson H et al. (2009) Up-regulation of O-GlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux. J Biol Chem 284:3425-32
Luo, Bai; Soesanto, Yudi; McClain, Donald A (2008) Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol 28:651-7
Soesanto, Yudi A; Luo, Bai; Jones, Deborah et al. (2008) Regulation of Akt signaling by O-GlcNAc in euglycemia. Am J Physiol Endocrinol Metab 295:E974-80
Taylor, Rodrick P; Parker, Glendon J; Hazel, Mark W et al. (2008) Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J Biol Chem 283:6050-7
Parker, Glendon; Taylor, Rodrick; Jones, Deborah et al. (2004) Hyperglycemia and inhibition of glycogen synthase in streptozotocin-treated mice: role of O-linked N-acetylglucosamine. J Biol Chem 279:20636-42
Parker, Glendon J; Lund, Kelli C; Taylor, Rodrick P et al. (2003) Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine. J Biol Chem 278:10022-7